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Available online 23 December 2016Kelch-like ECH-associatedprotein 1 (keap1) is a cysteine-rich protein that interactswith transcription factor Nrf2
in a redox-sensitivemanner, leading to the degradation of Nrf2 (Kim et al., 2014a). Disruption of Keap1 results in
the induction of Nrf2-related signaling pathways involving the expression of a set of anti-oxidant and anti-
inflammatory genes. We generated biallelic mutants of the Keap1 gene using a CRISPR-Cas9 genome editing
method in the H9 human embryonic stem cell (hESC). The Keap1 homozygous-knockout H9 cell line retained
normal morphology, gene expression, and in vivo differentiation potential.
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To engineer a biallelic mutation in the Keap1 gene, we introduced
preassembled Cas9 protein/single-chain guide RNA (sgRNA) ribonu-
cleoproteins (RNP) targeting the cysteine-rich N-terminal interven-
ing region (IVR) domain of Keap1 (Fig. 1A). The sgRNA-induced
indel frequency was measured 3 days post-transfection using T7 en-
donuclease I (T7E1), and the identity of the mutations was con-
firmed by deep sequencing (Fig. 1B, C). After single-cell seeding,
individual clones were picked and expanded. We confirmed the
targeted disruption of Keap1 by deep sequencing, which showed a
high rate of mutation (66%), with homozygous deletions occurring
in 13% of the clones.
For further characterization, we selected the H9Keap1KO-A31
line, with insertion of a biallelic single nucleotide (A) (Fig. 1D). The
H9Keap1KO-A31 line grew well, showed normal morphology
(Fig. 1E), and expressed the pluripotency markers OCT4, SSEA4,
TRA-1-60, and TRA-1-80 (Fig. 1F). The cell line had a stable karyo-
type (46, XX) (Fig. 1G). It also showed differentiation potential
which formed teratomas with tissues derived from all germlines, in-
cluding gut (endoderm), osteoid (mesoderm), and neuronal epithe-
lia and pigmented cells (ectoderm) (Fig. 1H). Additionally, mRNA
expression of the three germ layer markers was detected in 14-day
cultured embryonic bodies (EB) (Table 1). To confirm the safety of
the cell line, we tested for mycoplasma (data not shown), virus,
and bacterial infections (Fig. S1).er the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A) Schematic overview of the Keap1 gene and the Cas9/gRNA target site. B) Keap1-specific sgRNA RNP-mediated mutations measured with the T7E1 assay. C) Mutant DNA
sequences at the Keap1 locus. D) Sanger-sequencing of the H9Keap1KO-A31 line. E) Cell morphology. F) Image of immunostaining and G) karyotype. H) Image of an H&E-stained
teratoma (×40). Note the endoderm (gut), mesoderm (muscle, adipocytes), and ectoderm (stratified squamous epithelia) tissues. Table 1. The relative fold changes of gene expression
between EB and ES.
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here is karyotypically normal and retains pluripotency. It has the poten-
tial to offer insight into the roles of the Nrf2-Keap1 signaling pathway in
development.
2. Materials and methods
2.1. Cell culture
The human embryonic stem cell H9 was obtained from the WiCell
Research Institute (WA91; NIH Registration Number 0062) (Thomson
et al., 1998). Cellswere grown in E8medium (Gibco) onplates pre-coat-
ed with Laminin 521 (Corning). The cells were passaged using ReLeSR
(Stem Cell Technologies).
2.2. CRISPR-Cas9 gene editing
First, 40 μg of in-vitro transcribed sgRNA and 30 μg of recombinant
Cas9 protein were electroporated using the P3 Primary Cell 4D-
Nucleofector® X Kit (Lonza) (Kim et al., 2014b). After confirming
mutation with the T7E1 assay, genomic DNA was isolated using aQuickExtract genome isolation kit (Epicentre QE09050). The target re-
gion was amplified and subjected to paired-end read sequencing using
Illumina MiSeq at LAS (Table S1).
2.3. EB formation
The hESCs were detached from a Vitronectin (Gibco)-coated plate
using a cell scraper and transferred into a 15-mL conical tube. After a
gentle spin-down, the cells were resuspended in EB medium, which is
composed of Dulbecco's modified Eagle's medium (DMEM)/F12 medi-
um (Gibco), 20% knockout serum replacement (Gibco), 1% nonessential
amino acids (Gibco), and 0.1 mM β-mercaptoethanol (Invitrogen) and
cultured for 14 days.
2.4. Teratoma assay
First, 106 cellswere injected intoNODScidGamma(NOD.Cg-Prkdcscid
Il2rgtm1Wjl/SzJ) mice (Jackson Laboratory). After teratomas formed,
the mice were sacrificed, and the formaldehyde-fixed tumor tissues
were stained with hematoxylin and eosin (H&E).
54 S.-J. Kim et al. / Stem Cell Research 19 (2017) 52–542.5. Real-time quantitative PCR (qRT-PCR) analysis
Total RNA was extracted from the cells using the RNeasy Mini Kit
(QIAGEN 74106), according to the manufacturer's instructions. cDNA
was synthesized using RNA-to-cDNA EcoDry Premix (Clontech).
The qRT-PCR assays were performed using TaqMan™ Master Mix
(ABI) (Kim et al., 2014a).2.6. Immunostaining
The cells were fixed and permeabilized. The fixed samples were
incubated for 24 h at 4 °C with anti-Oct4 (Santa Cruz) or anti-SSEA-4
(Millipore) and with TRA-1-60 (Millipore), or TRA-1-81 (Millipore)
primary antibodies. Then, the samples were washed and incubated in
fluorescein-conjugated secondary antibodies with DAPI (Thermo).
Finally, the slides were photographed using an Olympus DP72 camera
and imaged with cellSens software.2.7. Karyotyping
The G-banding karyotype was analyzed in 20 single clones, and the
band resolution was 500.Conflict of interest
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